FDA Adverse Event Malfunction Summary report: N

ARCHITECT STAT MYOGLOBIN REAGENT KIT

MDR report key: 18896234 · Received March 13, 2024

Report

Report Number
1415939-2024-00027
Event Type
Malfunction
Date Received
March 13, 2024
Date of Event
February 16, 2024
Report Date
March 13, 2024
Manufacturer
ABBOTT LABORATORIES
Product Code
DDR
UDI-DI
00380740003302
PMA / PMN Number
K042924
Removal / Correction Number
1415939-02/27/2024-001-R
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

DURING THE INVESTIGATION INTO THIS ISSUE FOUND THAT DURING MANUFACTURING, THE MICROPARTICLE CONCENTRATE USED IN REAGENT LOT NUMBER 50808UN23 WAS NOT PROPERLY MIXED. AS A RESULT, AN INSUFFICIENT AMOUNT OF MICROPARTICLES WAS ADDED TO REAGENT LOT 50808UN23. A PRODUCT RECALL LETTER WAS ISSUED ON 21FEB2024 TO ALL CUSTOMERS WHO HAVE RECEIVED SHIPMENTS OF ARCHITECT STAT MYOGLOBIN REAGENT LOT NUMBERS 50808UN23. THE PRODUCT RECALL LETTER NOTIFIES THE CUSTOMER OF THE ISSUE AND THE POTENTIAL IMPACT TO PATIENT RESULTS WITH USE OF LOT 50808UN23. THE PRODUCT RECALL LETTER INSTRUCTS CUSTOMERS TO DISCONTINUE USE OF AND DESTROY ANY REMAINING INVENTORY OF LOT 50808UN23 ACCORDING TO THEIR LABORATORY PROCEDURES AND IMMEDIATELY CONTACT CUSTOMER SUPPORT TO ORDER A REPLACEMENT PRODUCT.

Description of Event or Problem · 0

THE CUSTOMER OBSERVED QUALITY CONTROLS RESULTS WERE OUT OF RANGE LOW WHILE USING ARCHITECT STAT MYOGLOBIN REAGENT LIST 02K43-25, LOT 50808UN23. FOLLOWING QC DATA WAS PROVIDED. L1 29.6 (20.7¿38.5) L2 89.6 (71.7¿107) L3 227 (182¿273) QC DATA FROM THE IMPACTED LOT AND DIFFERENT LOT 50808UN23 DIFFERENT NEW REAGENT L1 29.6 (20.7¿38.5) 24.0 L2 89.6 (71.7¿107) 76.5 L3 227 (182¿273) 175.2 THERE WAS NO IMPACT TO PATIENT MANAGEMENT OR USERS¿ SAFETY WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
192172 ARCHITECT STAT MYOGLOBIN REAGENT KIT MYOGLOBIN, ANTIGEN, ANTISERUM, CONTROL DDR ABBOTT LABORATORIES 50808UN23 00380740003302

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown ARC I1000SR MOD, 01L86-01, I1SR60965